Spyre Therapeutics
SYRE
#3546
Rank
ยฃ2.80 B
Marketcap
ยฃ35.68
Share price
-0.44%
Change (1 day)
161.20%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A-100%
2023 ยฃ0.69 M-63.87%
2022 ยฃ1.92 M-86.13%
2021 ยฃ13.88 M
2020 N/A
2019 N/A-100%
2018 ยฃ3.06 M-20.45%
2017 ยฃ3.85 M2.66%
2016 ยฃ3.75 M-8.66%
2015 ยฃ4.1 M
2014 N/A